Navigation Links
Quest Diagnostics Sponsors American Cancer Society's Choose You® Movement

MADISON, N.J., May 9, 2011 /PRNewswire/ -- Quest Diagnostics, the world's leading provider of diagnostic testing, information and services (NYSE: DGX), today announced its national sponsorship of Choose You®, the American Cancer Society's movement that inspires women to stay well by putting their health first and making healthy lifestyle choices to help prevent cancer. According to the American Cancer Society, 1 in 3 American women will get cancer in her lifetime, but there are steps women can take today to help change that statistic. More than half of cancer deaths could be prevented with healthy lifestyle choices, like maintaining a healthy weight through diet and regular exercise, avoiding tobacco products and getting regular cancer screening tests.

"We look forward to working with Quest Diagnostics as a national sponsor of the Choose You 'get regular health checks' commitment," said Terry Music, chief mission delivery officer for the American Cancer Society. "Their support will go a long way in helping women put their health first."

As part of the movement, women are encouraged to sign a Choose You Commitment, an online pledge to reach a specific, individual health goal. At, women can choose from five different health categories: eat right; get active; get regular health checks; protect your skin; and quit smoking. Quest Diagnostics is the national sponsor of the Choose You effort to remind women to 'get regular health checks.'

"Quest Diagnostics is proud to be a national sponsor of this important public health initiative," said Laure Park, Vice President, Corporate Communications and Investor Relations and the company's Corporate Citizenship Officer. "We hope that many will join us in supporting the Choose You movement, in recognizing women everywhere who care for their families, and in reminding them to also care for themselves."

Jon R. Cohen, M.D., Quest Diagnostics Senior Vice President and Chief Medical Officer said, "Our work at Quest Diagnostics is to put patients first every day. In doing so, we witness firsthand how prevention and early detection can change a life. By inspiring women to see their doctors and get their regular health checks, the American Cancer Society and its Choose You movement have the power to make a difference in American health – and for American families."

Quest Diagnostics is the world's leader in cancer diagnostics and is nationally recognized for its commitment to the health and wellness of its employees. In 2010, the company earned Cancer Gold Standard accreditation from the CEO Roundtable on Cancer in recognition of its commitment to its employees through the cancer continuum, from prevention and early detection to diagnosis, treatment and care. Quest Diagnostics Chairman, CEO and President Surya N. Mohapatra is an inaugural member of the American Cancer Society's CEOs Against Cancer® New Jersey Chapter, and the company is a 2010 Platinum Employer for Healthy Lifestyles award recipient from the National Business Group on Health for its HealthyQuest employee wellness program.

To learn more, visit

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at:

Contacts: Barb Short, Media, 973-520-2800; Kathleen Valentine, Investors, 973-520-2900

SOURCE Quest Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
3. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
4. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
5. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
6. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
7. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
10. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
Post Your Comments:
(Date:11/29/2015)... , Nov. 29, 2015   Royal Philips  ... driven radiology solutions at the 2015 Radiological Society of ... 4 at McCormick Place in Chicago ... will experience the company,s broad portfolio of integrated Diagnostic ... solutions to increase clinical performance, improve workflow and create ...
(Date:11/29/2015)... Germany , Nov. 29, 2015  At this ... attendees to experience the most complete mobile C-arm portfolio ... display is Ziehm Vision RFD 3D, the world,s only ... cm edge length per scan volume. In addition, Ziehm ... fully motorized mobile C-arm in four axes which is ...
(Date:11/29/2015)...  The GE Health Cloud 1 was unveiled today ... North America (RSNA) meeting in ... new cloud ecosystem and its applications will connect radiologists and ... multidisciplinary teams – both inside and outside the hospital setting. ... GE. "As the digital industrial leader, we are betting big ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... , ... Khanna Vision Institute based in Los Angeles, announced that Dr. Khanna ... Peer Certification by the Board is done so the public knows that the Doctor ... after the completion of three years of training or Residency in Ophthalmology. This is ...
(Date:11/29/2015)... PITTSBURGH, PA (PRWEB) , ... November 29, 2015 , ... ... assistance with kneeling or provide ready access to exercise weights. Fortunately, an inventor from ... prototype for THE TOMMY WALKER to enhance the benefits of a standard walker to ...
(Date:11/29/2015)... ... 29, 2015 , ... Doctors who missed a case of mesothelioma in a ... mesothelioma and push for a diagnosis, especially in people exposed to asbestos. Surviving Mesothelioma ... read it now. , Researchers at Gifu Prefectural Tajimi Hospital in Japan ...
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion from ... designed specially for Final Cut Pro X. FCPX users can now ... modification controls. Destoying and creating chaotic distortion is now quick and simple, putting ...
(Date:11/29/2015)... ... ... Effective immediately, every single IguanaMed scrub style will be available at Target via ... “Buy One Scrub Set, Get the 2nd Scrub Set 50% Off” for a limited ... price. , IguanaMed’s mission is to outfit every healer around the world ...
Breaking Medicine News(10 mins):